Literature DB >> 26890457

Evaluation of Volumetric Changes of Augmented Maxillary Sinus With Different Bone Grafting Biomaterials.

B Alper Gultekin1, Erol Cansiz, Oguz Borahan, Carlo Mangano, Roni Kolerman, Eitan Mijiritsky, Serdar Yalcin.   

Abstract

Extensive alveolar bone resorption because of pneumatized maxillary sinus is a common problem that limits dental implant placement. Maxillary sinus floor augmentation (MSFA) is an accepted treatment protocol that provides sufficient bone volume. The aim of this study was to evaluate the percentage of graft volume reduction following MSFA using cone beam computed tomography. In this retrospective study, cone beam computed tomography scans of MSFA were measured to evaluate the volume of the grafted sinus with deproteinized bovine bone (DBB), mineralized allograft (MA), or a mixture of MA and demineralized allograft as a composite. The volumetric changes in sinus augmentation between 2 weeks (T-I) and 6 months (T-II) after operation were analyzed. Thirty-nine patients were included in this study. The average percent volume reduction was 8.14 ± 3.76%, 19.38 ± 9.22%, and 24.66 ± 4.68% for DBB, MA, and composite graft, respectively. A significant graft volume reduction was found between T-I and T-II for all groups (P < 0.01). The DBB group showed the least volume reduction (P < 0.01). Biomaterials can influence the bone graft volume change before implant placement. Deproteinized bovine bone may offer greater volume stability during healing than mineralized and composite allografts.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26890457     DOI: 10.1097/SCS.0000000000002393

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  7 in total

1.  Effect of amount of biomaterial used for maxillary sinus lift on volume maintenance of grafts.

Authors:  Luciene-Dornas Mendes; Roberta-Paula-Colen Bustamante; Bruno-César-Ladeira Vidigal; Mario-Nazareno Favato; Flávio-Ricardo Manzi; Mauricio-Greco Cosso; Elton-Gonçalves Zenóbio
Journal:  J Clin Exp Dent       Date:  2020-09-01

2.  Radiographic Comparison of Bovine Bone Substitute Alone Versus Bovine Bone Substitute and Simvastatin for Human Maxillary Sinus Augmentation.

Authors:  Siamak Yaghobee; Amir Ali Reza Rasouli Ghahroudi; Afshin Khorsand; Sanaz Mahmoudi; Sahar Chokami Rafiei
Journal:  J Dent (Tehran)       Date:  2018-01

Review 3.  Maxillary Sinus Floor Augmentation with Autogenous Bone Graft Compared with a Composite Grafting Material or Bone Substitute Alone: a Systematic Review and Meta-Analysis Assessing Volumetric Stability of the Grafting Material.

Authors:  Thomas Starch-Jensen; Daniel Deluiz; Julie Vitenson; Niels Henrik Bruun; Eduardo Muniz Barretto Tinoco
Journal:  J Oral Maxillofac Res       Date:  2021-03-31

4.  Characterizing the respiratory-induced mechanical stimulation at the maxillary sinus floor following sinus augmentation by computational fluid dynamics.

Authors:  Qing Li; Zhongyu Wang; Chao Wang; Hom-Lay Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-07-26

5.  Clinical and radiographic outcomes following transcrestal maxillary sinus floor elevation with injectable xenogenous bone substitute in gel form: a prospective multicenter study.

Authors:  Teresa Lombardi; Luca Lamazza; Fabio Bernardello; Grzegorz Ziętek; Claudio Stacchi; Giuseppe Troiano
Journal:  Int J Implant Dent       Date:  2022-07-22

6.  Hydrophilicity, Viscoelastic, and Physicochemical Properties Variations in Dental Bone Grafting Substitutes.

Authors:  Branko Trajkovski; Matthias Jaunich; Wolf-Dieter Müller; Florian Beuer; Gregory-George Zafiropoulos; Alireza Houshmand
Journal:  Materials (Basel)       Date:  2018-01-30       Impact factor: 3.623

7.  Histologic, Histomorphometric, and Clinical Analysis of the Effects of Growth Factors in a Fibrin Network Used in Maxillary Sinus Augmentation.

Authors:  Ihsan Caglar Cinar; Bahattin Alper Gultekin; Alper Saglanmak; Serdar Yalcin; Vakur Olgac; Eitan Mijiritsky
Journal:  Int J Environ Res Public Health       Date:  2020-03-15       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.